Marilyn J. Schlitz, PhD Sources:

Distant Healing Intention and Therapeutic Outcomes

Distant healing intention (DHI), the deliberate attempt by one person to benefit another’s health across a physical separation that precludes ordinary sensory contact, is among the most widely practiced yet scientifically contested forms of complementary medicine. Schlitz has spent several decades examining DHI through controlled laboratory paradigms and randomized clinical trials, contributing both primary data and integrative reviews that map the field’s evidential landscape. A persistent Type-II vulnerability in this literature is that true effects, if they exist, are likely small in magnitude and state-dependent, meaning that underpowered single studies will routinely fail to detect them even if the phenomenon is real.

Key findings

  • A meta-analysis of 30 controlled laboratory experiments found significant autonomic nervous system activation in distant receivers during intention periods compared with randomly interspersed control periods.1
  • A double-blind study of 36 couples, including 22 in which one partner was a cancer patient, found that receivers’ skin conductance increased significantly during intention epochs (z = 3.9, p = .00009, two-tailed), with the largest effects in trained, motivated pairs.2
  • An exploratory randomized trial of distant healing for post-surgical wounds found no statistically significant effect on wound healing outcomes, illustrating the gap between laboratory and clinical results.3
  • Schlitz’s integrative review concluded that controlled laboratory studies offer support for a transpersonal dimension to DHI, while results from randomized clinical trials remain more equivocal.4
  • Intentionality has been proposed as a unifying concept for integrating body, mind, and spirit in healing research, spanning self-healing, placebo-mediated effects, and putative nonlocal influences.5
  • A broad scientific overview identified DHI as one of the most commonly used complementary and alternative medicine modalities, with prayer for others ranking second in a US national health survey, underscoring the public-health relevance of rigorous investigation.6

Overview

Distant healing intention is defined as a conscious, dedicated act of mentation attempting to benefit another person’s physical or emotional well-being at a distance, a definition that encompasses intercessory prayer, Reiki, non-contact Therapeutic Touch, shamanic healing, and intentionality-based energy work.4 Schlitz’s research program treats intentionality as a potential unifying concept for alternative medicine: rather than treating each healing modality as a separate phenomenon, she frames them as variations on a common theme, the projection of awareness, with purpose and efficacy, toward another’s well-being.5 This framing creates a testable research agenda that can be pursued through both tightly controlled laboratory paradigms and real-world clinical trials, and it is the thread connecting her work from the Mind Science Foundation through the Institute of Noetic Sciences and beyond.

Defining DHI: Scope and Terminology

Schlitz and Braud’s 1997 review1 catalogued the terminological diversity in the field: transpersonal imagery, intercessory prayer, spiritual healing, non-directed prayer, intentionality, energy healing, shamanic healing, non-local healing, non-contact Therapeutic Touch, and Reiki are all treated as DHI variants. Each involves a distinct theoretical, theological, cultural, or pragmatic approach, but all share the assumption that healing can occur under conditions that transcend conventional sensory communication, a claim that challenges standard causal ontology. Schlitz’s 2014 review4 noted that a US National Center for Health Statistics survey ranked prayer for self as the most popular complementary and alternative medicine practice among American adults, and prayer for others as the second most popular, making DHI a phenomenon of substantial public-health relevance regardless of its ultimate mechanistic status.

Laboratory Foundations: DMILS and Autonomic Measures

The most controlled body of evidence for DHI comes from laboratory paradigms in which a sender directs intention toward a distant, shielded receiver while physiological measures, primarily electrodermal activity (skin conductance), are recorded in the receiver. Schlitz’s decade-long collaboration with William Braud at the Mind Science Foundation produced a substantial corpus of such studies, and their 1997 meta-analysis of 30 formal experiments found a significant and characteristic variation in autonomic activity during distant intentionality periods compared with randomly interspersed control periods.1 The proposed mechanism, that one person’s conscious intention can influence another’s autonomic nervous system across a physical barrier, remains contested; the researcher’s preferred interpretation invokes a nonlocal dimension of consciousness, while alternative interpretations include undetected sensory leakage, shared physiological rhythms, or statistical artifacts from optional stopping.

Meta-Analytic Results: 30 DMILS Experiments

The Schlitz and Braud 1997 meta-analysis1 synthesized 30 formal experiments in which self-reported healers, “psychics,” and other self-selected volunteers attempted to influence autonomic nervous system activity in a distant person. The primary outcome measure was electrodermal activity (skin conductance level) recorded during intention periods versus randomly interspersed control periods. Results across the 30 experiments showed a significant and characteristic variation during distant intentionality periods. The review explicitly considered possible alternative explanations including suggestion and self-regulation, arguing that the experimental design, physical isolation of sender and receiver, random scheduling of intention epochs, and physiological rather than self-report outcome measures, mitigated but did not fully eliminate these alternatives. The review noted that the effect was not uniform across studies and that healer selection, motivation, and training were potential moderators. No independent replication of the full 30-study meta-analysis by a skeptical research team is reported in the pool.

Schlitz has consistently argued that intentionality represents a unifying concept for the study of alternative therapies, one that can bridge self-healing (where psychoneuroimmunological mechanisms are uncontroversial), placebo-mediated effects (where indirect communication is the operative pathway), and putative nonlocal healing (where the causal pathway remains unknown).5 This three-tier model is important because it frames the DHI question not as a binary (real or not) but as a question about which causal pathway is operative in any given context, a framing that has methodological implications for how studies should be designed to distinguish among them.

Intentionality as a Unifying Framework

In her 1995 paper,5 Schlitz outlined three research domains for intentionality in healing: (1) self-healing, where intentions interact with one’s own body via psychoneuroimmunological and biofeedback mechanisms; (2) indirect influence on others through placebo and “noxebo” effects, where communication is the operative pathway; and (3) nonlocal influence on others, where healing occurs under conditions that preclude conventional mind-body interactions. She identified methodological challenges specific to each tier, for self-healing, the difficulty of controlling for unconscious self-regulatory processes; for placebo effects, the challenge of constructing appropriate blinds; and for nonlocal healing, the fundamental epistemological challenge of ruling out all known causal pathways. The paper argued that remissions research, well-documented cases of recovery against medical odds, represented an underexplored natural-history resource for understanding self-healing mechanisms. No specific effect sizes are reported in this conceptual paper.

Clinical Trials: From Lab to Bedside

Translating laboratory DHI findings into clinical settings has proven substantially more difficult. Schlitz’s 2012 exploratory randomized trial of distant healing for post-surgical wounds, conducted at California Pacific Medical Center, found no statistically significant effect on wound healing outcomes, illustrating the gap between controlled laboratory paradigms and the complexity of real-world clinical contexts.3 Her 2014 integrative review concluded that while controlled laboratory studies offer support for a transpersonal dimension to DHI, results from randomized clinical trials are more equivocal and do not yet provide clear evidence to support DHI as an evidence-based clinical modality.4

Distant Healing of Surgical Wounds, 2012 Exploratory Trial

The Schlitz et al. 2012 study3 was conducted at California Pacific Medical Center and examined whether distant healing intention directed toward post-surgical patients would accelerate wound healing compared with a control condition. The study was explicitly described as exploratory. Patients and wound assessors were blinded to healing assignment, addressing the artifact of demand characteristics and expectancy effects on outcome ratings. The null result on the primary wound-healing outcome is notable because it came from a team that had previously found positive effects in laboratory paradigms, suggesting that the translation from tightly controlled physiological measures (skin conductance) to complex clinical outcomes (tissue repair) introduces confounds that the laboratory design does not. The paper is cited in the broader DHI literature as an example of the methodological challenges facing clinical translation of laboratory psi findings.

The broader scientific overview co-authored by Schlitz and Radin situates this lab-to-clinic gap within the wider DHI literature, noting that the field spans a diverse array of healing modalities and outcome measures, making cumulative synthesis difficult.6 Standardization of healer selection criteria, intention protocols, outcome measures, and blinding procedures has been identified as a prerequisite for meaningful meta-analytic synthesis across clinical trials.7

Guidelines for Laboratory DHI Studies

Schlitz et al. 20037 addressed the methodological complexity of differentiating among psychological, psychosocial, and psychic influences in intentional healing research. The paper discussed experimenter effects (the finding that the experimenter’s own beliefs and expectations can influence outcomes, a phenomenon Schlitz herself demonstrated in the Wiseman collaboration), patient expectation effects, baseline psychological factors as predictors of medical outcomes, and experimental design questions including healer selection criteria, structure and duration of the intervention, and the construction of appropriate blinds. The paper argued that these design variables must be standardized before cross-study comparisons are meaningful. It also noted that the distinction between self-healing (psychoneuroimmunological) and nonlocal healing (putatively transpersonal) cannot be made on the basis of outcome data alone, the causal pathway must be independently assessed.

Modern Context

The methodological challenges Schlitz identifies in DHI clinical trials, blinding, placebo control, outcome standardization, and the lab-to-clinic translation problem, are not unique to parapsychology. The broader scientific overview co-authored with Radin6 situates DHI research within the wider complementary and alternative medicine literature. The Cochrane systematic review of placebo interventions across all clinical conditions (Hróbjartsson & Gøtzsche, 2010) found that placebo effects on objective outcomes are generally small and inconsistent across study designs, with larger apparent effects largely confined to patient-reported subjective outcomes and to studies with high risk of bias8 — the same clinical-null baseline against which the 2012 wound-healing primary-outcome null must be read. Schlitz’s 2014 review4 explicitly frames the equivocal clinical trial results as reflecting epistemological and ontological challenges that are not yet resolved by existing research designs, rather than as definitive disconfirmation, a position consistent with the Type-II vulnerability noted in the overview above.

Compassionate Intention and Cancer Patients

The most methodologically detailed study in Schlitz’s DHI portfolio examined whether a trained partner’s compassionate intention could produce measurable autonomic changes in a cancer patient located in a distant, shielded room. The 2008 Radin, Stone, Levine, Eskandarnejad, Schlitz et al. study (N = 36 couples, 38 test sessions) found that receivers’ skin conductance increased significantly during intention epochs overall, with post-hoc analysis suggesting that training and motivation moderated the effect size.2 The researcher’s preferred interpretation is that compassionate intention directed toward a distant person is correlated with activation of that person’s autonomic nervous system, and that training on how to cultivate and direct intention may enhance this effect. Alternative interpretations, including shared physiological rhythms between intimately bonded couples, undetected low-frequency electromagnetic coupling, or statistical inflation from the post-hoc moderator analysis, are not fully ruled out by the design.

Design, Sample, and Statistical Results, 2008 Cancer Intention Study

Radin, Stone, Levine, Eskandarnejad, Schlitz et al. 20082 enrolled 36 couples in 38 test sessions. In 22 couples, one partner was a cancer patient; in 12 of those couples, the healthy partner had been trained to direct intention toward the patient and had practiced daily for three months prior to the experiment (trained group). In 10 couples, the pair was tested before the partner received training (wait group). Fourteen healthy couples received no training (control group). Skin conductance level was measured simultaneously in both members of each couple. The sending person directed intention toward the receiver during repeated 10-second epochs separated by random interepoch periods; the receiver relaxed in a distant shielded room for 30 minutes per session. The primary outcome, normalized skin conductance means during intention epochs versus randomly selected interepoch control periods, was assessed using nonparametric bootstrap procedures. The overall result was z = 3.9, p = .00009 (two-tailed), indicating significantly elevated skin conductance during intention epochs across all groups. The preplanned group comparison (trained vs. wait vs. control) was not significant. A post-hoc analysis showed that peak deviations were largest and most sustained in the trained group, followed by the wait group, then the control group. The post-hoc nature of this moderator finding means it carries exploratory rather than confirmatory weight and requires independent replication with a preregistered group-comparison hypothesis. The artifact of shared physiological rhythms between intimately bonded couples, which could produce correlated skin conductance fluctuations independent of intention, was partially addressed by the shielded room design (eliminating direct sensory contact) but not fully eliminated, as low-frequency physiological coupling mechanisms are not fully understood.

This study is notable for its attempt to move DHI research toward a clinically relevant population, cancer patients and their partners, and for its explicit attention to motivation and training as potential moderators of the effect. The finding that the overall effect was significant while the planned group comparison was not illustrates a recurring tension in DHI research: aggregate effects emerge across heterogeneous samples, but the moderating variables that would explain who benefits and under what conditions remain incompletely characterized.6

Motivation, Training, and Moderator Variables in DHI

The 2008 study’s post-hoc finding that trained, motivated cancer-patient couples showed the largest autonomic effects2 aligns with a broader theoretical claim in Schlitz’s work: that the quality of the sender’s intention, its depth, training, and motivational grounding, is a meaningful variable, not merely a binary on/off switch. This claim has methodological implications: if motivation and training are genuine moderators, then studies using untrained volunteers as senders may systematically underestimate effect sizes relative to studies using experienced healers or intimately bonded partners. Schlitz’s 2003 guidelines paper7 identified healer selection and training as among the most important unresolved design variables in the field. The 2015 overview by Radin and Schlitz6 noted that heterogeneity in healer selection across studies is a primary source of between-study variance in DHI meta-analyses, making pooled effect-size estimates difficult to interpret.

Skeptical Critiques and Discussion

Critique 1: Clinical trial results are equivocal and do not support DHI as an evidence-based modality

Skeptic source: The most direct challenge to DHI research comes from within the field itself: Schlitz’s own integrative review acknowledges that results of randomized controlled clinical trials are more equivocal than laboratory results and do not offer clear evidence to support DHI as an evidence-based modality.4 The 2012 surgical wounds trial, conducted by Schlitz’s own team under double-blind conditions addressing demand characteristics and expectancy effects on wound assessors, produced a null result on the primary clinical outcome.3 The wider clinical-trial baseline documented by the Cochrane systematic review of placebo interventions describes placebo effects on objective outcomes as generally small and inconsistent8; the DHI wound-healing null reads as broadly consistent with that baseline rather than as an isolated anomaly, though neither reading forecloses the laboratory-to-clinic translation question Schlitz raises in response.

Response: Schlitz’s response, embedded in the same review, is that the null clinical results reflect the methodological gap between tightly controlled laboratory physiological measures and the complexity of clinical outcomes, not necessarily the absence of a real effect.4 Laboratory paradigms using skin conductance as the outcome measure isolate the putative effect from confounds (disease progression, co-interventions, patient psychology) that are unavoidable in clinical settings. The 2008 cancer-patient study, which used the laboratory skin-conductance paradigm with a clinically relevant population, found a significant overall effect (z = 3.9, p = .00009), suggesting that the laboratory signal does not disappear when the sample is clinically motivated.2

Analysis. Laboratory and clinical results point in different directions. The laboratory meta-analytic signal is statistically significant across 30 studies,1 but the clinical translation has not yet produced a significant primary outcome in a randomized trial. The gap between these two bodies of evidence is real and unresolved.

Critique 2: Post-hoc moderator analyses inflate apparent effect sizes and cannot be treated as confirmatory

Skeptic source: The 2008 cancer-patient study’s most theoretically interesting finding, that trained, motivated couples showed the largest autonomic effects, was a post-hoc analysis conducted after the preplanned group comparison failed to reach significance.2 Post-hoc moderator analyses in small samples (N = 36 couples) are vulnerable to multiple-comparisons inflation and capitalization on chance, and the training-moderator finding has not been independently preregistered and replicated.

Response: The study’s authors explicitly acknowledged the post-hoc nature of the moderator analysis and framed it as hypothesis-generating rather than confirmatory.2 The overall primary result, elevated skin conductance during intention epochs across all groups (z = 3.9, p = .00009), was based on a preplanned comparison using nonparametric bootstrap procedures, and this result does not depend on the post-hoc moderator finding. Schlitz’s 2003 guidelines paper identified healer training and motivation as variables that should be preregistered in future studies precisely to address this concern.7

Analysis. The post-hoc moderator finding carries exploratory weight only and should not be cited as confirmatory evidence for training effects. The overall preplanned result is on stronger methodological footing, though the absence of preregistration for the study as a whole means the stopping rule and primary-outcome designation cannot be independently verified.

References
  1. Schlitz, M., & Braud, W. G. (1997). Distant Intentionality and Healing: Assessing the Evidence. Alternative Therapies in Health and Medicine, 3(6), 62–73. https://pubmed.ncbi.nlm.nih.gov/9375431/ [Schlitz & Braud 1997] R001 ↩︎
  2. Radin, D. I., Stone, J., Levine, E., Eskandarnejad, S., Schlitz, M., Kozak, L., … Hayssen, G. (2008). Compassionate intention as a therapeutic intervention by partners of cancer patients: Effects of distant intention on the patients’ autonomic nervous system. Explore: The Journal of Science and Healing, 4(4), 235–243. https://doi.org/10.1016/j.explore.2008.04.002 [Radin 2008] R002 ↩︎
  3. Schlitz, M., Hopf, H. W., Eskenazi, L., Vieten, C., et al. (2012). Distant Healing of Surgical Wounds: An Exploratory Study. EXPLORE, 8(4), 223–230. https://doi.org/10.1016/j.explore.2012.04.005 [Schlitz 2012] R003 ↩︎
  4. Schlitz, M. (2014). Transpersonal Healing: Assessing the Evidence from Laboratory and Clinical Trials. International Journal of Transpersonal Studies. https://digitalcommons.ciis.edu/ijts-transpersonalstudies/vol33/iss1/10 [Schlitz 2014] R004 ↩︎
  5. Schlitz, M. J. (1995). Intentionality in Healing: Mapping the Integration of Body, Mind, and Spirit. Alternative Therapies in Health and Medicine, 1(5), 119–120. marilynschlitz.com (PDF) [Schlitz 1995] R005 ↩︎
  6. Radin, D. I., Schlitz, M., & Baur, C. (2015). Distant Healing Intention Therapies: An Overview of the Scientific Evidence. Global Advances in Health and Medicine, 4(1_suppl), 67–71. https://doi.org/10.7453/gahmj.2015.012.suppl [Radin 2015] R006 ↩︎
  7. Schlitz, M., Radin, D. I., Malle, B. F., Schmidt, S., Utts, J., & Yount, G. L. (2003). Distant healing intention: Definitions and evolving guidelines for laboratory studies. Alternative Therapies in Health and Medicine, 9(3 Suppl), A31–A43. pubmed.ncbi.nlm.nih.gov/12776476 [Schlitz 2003] R007 ↩︎
  8. Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003974.pub3 [Hróbjartsson 2010] R008 ↩︎

Last updated: 2026-07-03 18:26:38

Copyright © 2026 Innovative Software Design. All rights reserved.

ESP-Nexus reports published parapsychology research as written by its own authors. Source-fidelity to cited documents is audited on every page; the site takes no position on the epistemic status of parapsychological claims themselves.